ライフサイエンスコーパス: embryonated

1 This study examined the fate of embryonated and unembryonated Ascaris suum ova in six la

2 ed exclusively in Vero cells, MDCK cells, or embryonated chicken eggs (hereafter referred to as eggs)

3 S1] restores impaired growth to wt levels in embryonated chicken eggs and CEFs.

4 These rNDV mutants grow poorly in both embryonated chicken eggs and chicken embryo fibroblasts

5 /02 virus lineages did not replicate well in embryonated chicken eggs and had to be isolated original

6 ent system to produce cost-effective VLPs in embryonated chicken eggs and has the potential to be use

7 of influenza virus: virus isolation (VI) in embryonated chicken eggs and hemagglutinin subtyping by

8 This virus was propagated using embryonated chicken eggs and inoculated into a duck via

9 generated and evaluated for their growth in embryonated chicken eggs and their immunogenicity and pr

10 e neuraminidase (NA) stalk, does not grow in embryonated chicken eggs because of defective NA functio

11 as wild-type (WT) virus in MDCK cells and in embryonated chicken eggs but is highly attenuated in mic

12 nt viruses grew to high titers in 10-day-old embryonated chicken eggs but were attenuated in mammalia

13 rescued viruses grew well and were stable in embryonated chicken eggs over multiple passages.

14 otein in DF1 cells and in allantoic fluid of embryonated chicken eggs than did the conventional vecto

15 of the recombinant virus after passage into embryonated chicken eggs was identical to that of the in

16 creased A/Fujian/411/02 virus replication in embryonated chicken eggs were found to have no significa

17 ire an alternative host cell system, because embryonated chicken eggs will likely be insufficient and

18 n of human subtype H3N2 influenza viruses in embryonated chicken eggs yields viruses with amino acid

19 analysis of viral pathogenicity in 9-day-old embryonated chicken eggs, 1-day-old and 2-week-old chick

20 analysis of viral pathogenicity in 9-day-old embryonated chicken eggs, 1-day-old chicks, and 2-week-o

21 ogenicity of mutant viruses was evaluated in embryonated chicken eggs, 1-day-old chicks, and 6-week-o

22 This PR8 backbone also improves titres in embryonated chicken eggs, a common propagation system fo

23 t on the neutralization of NDV purified from embryonated chicken eggs, a common source for virus prod

24 ally related strains that replicated well in embryonated chicken eggs, A/Sendai-H/F4962/02 and A/Wyom

25 absence of trypsin, caused death in mice and embryonated chicken eggs, and displayed a high-growth ph

26 ruses were viable, grew to similar titers in embryonated chicken eggs, and expressed Gag in a stable

27 6/98, which yields relatively high titers in embryonated chicken eggs, between RNA polymerase I and R

28 In embryonated chicken eggs, the parental virus grew to hig

29 cell culture and in experimentally infected embryonated chicken eggs.

30 or-binding domain on the HA globular head in embryonated chicken eggs.

31 te of replication of the parental strains in embryonated chicken eggs.

32 tant viruses replicated relatively poorly in embryonated chicken eggs.

33 on HA for a reassortant H5N1 strain grown in embryonated chicken eggs.

34 to the same titer in MDCK (canine) cells or embryonated chicken eggs.

35 ct on virus replication in MDCK cells and in embryonated chicken eggs.

36 following several passages in MDCK cells or embryonated chicken eggs.

37 hogen were available, and the isolate killed embryonated chicken eggs.

38 hown to be stable after multiple passages in embryonated chicken eggs.

39 enza virus production in both cell lines and embryonated chicken eggs.

40 rulent because of a short mean death time in embryonated chicken eggs.

41 rus in Madin-Darby canine kidney cells or in embryonated chicken eggs.

42 Nine Mile phase I (NMI) strain purified from embryonated egg yolk sac preparations.

43 ethods could provide benefits over classical embryonated-egg technology, including a higher productio

44 3 adjuvant system or 15 microg of plain HA), embryonated-egg-derived vaccines (3.75 microg of HA with

45 opment of influenza vaccines that do not use embryonated eggs as the substrate for vaccine production

46 rently being considered as an alternative to embryonated eggs for influenza virus propagation and hem

47 containing a fibronectin-binding domain into embryonated eggs increased the survival rate of virus-in

48 poration of chicken RCA into NDV produced in embryonated eggs similarly provided species specificity

49 and the maintenance of a constant supply of embryonated eggs would be difficult in a pandemic.

50 ed in Vero or CEF cells but was recovered in embryonated eggs, suggesting that VP2 contains the deter

51 improved vaccine yield by 10-fold in chicken embryonated eggs, the substrate for vaccine manufacture.

52 f recently isolated viruses, particularly in embryonated eggs.

53 ent to the amount of HA obtained from 10,000 embryonated eggs.

54 potential problems with the availability of embryonated eggs.

55 vel and is overexpressed in dauer larvae and embryonated eggs.

56 of which was recovered after propagation in embryonated eggs.

57 in frequency during passage of the virus in embryonated eggs.

58 ammalian cells and mice, yet it grew well in embryonated eggs.

59 ssed and active in rickettsiae isolated from embryonated hen egg yolk sacs.

60 ansplants on the chorioallantoic membrane of embryonated hen eggs showed reduced tumor-induced angiog

61 iently as the parental recombinant strain in embryonated hen eggs, in MDCK cells, or in vivo in a mou

62 In embryonated hen's eggs and leucopenic mice, the outcome

63 ay was used to monitor gene expression in de-embryonated rice grains.